RISK OF KIDNEY DISEASE PROGRESSION AND EFFICACY OF SGLT2 INHIBITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Moura F, Berg D, Bellavia A, Mosenzon O, Dwyer J, Scirica B, Wiviott S, Bhatt D, Raz I, Feinberg M, Morrow D, Sabatine M. RISK OF KIDNEY DISEASE PROGRESSION AND EFFICACY OF SGLT2 INHIBITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Journal Of The American College Of Cardiology 2023, 81: 1808. DOI: 10.1016/s0735-1097(23)02252-0.Peer-Reviewed Original ResearchRisk of kidney disease progressionType 2 diabetes mellitusKidney disease progressionSGLT2 inhibitionDisease progression